Global Health Limited (IN:MEDANTA)
:MEDANTA
Top Page
Global Health Limited
(MEDANTA)
Select Model
Select Model
Rating:65Neutral
Price Target:
₹1,111.00
▼(-8.68% Downside)
Action:DowngradedDate:11/11/25
Global Health Limited's strong financial performance is a key strength, supported by robust revenue growth and efficient operations. However, technical indicators suggest bearish momentum, and the high P/E ratio indicates potential overvaluation. The lack of earnings call data and corporate events limits further insights.
Positive Factors
Consistent Revenue Growth
Sustained top-line growth (12.7% year over year) indicates durable demand for tertiary/quaternary hospital services and expanding patient volumes or case mix. Over 2–6 months this underpins reinvestment capacity, supports margin maintenance and funds strategic expansion of specialties.
Negative Factors
Volatile Free Cash Flow
A marked drop and volatility in free cash flow reduces predictability of internal funding for capex, expansion or payouts. Over the medium term this can force timing changes to investments, raise reliance on external financing in capex cycles, and increase execution risk.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistent Revenue Growth
Sustained top-line growth (12.7% year over year) indicates durable demand for tertiary/quaternary hospital services and expanding patient volumes or case mix. Over 2–6 months this underpins reinvestment capacity, supports margin maintenance and funds strategic expansion of specialties.
Read all positive factors
Global Health Limited (MEDANTA) vs. iShares MSCI India ETF (INDA)
Market Cap
₹277.16B
Dividend Yield0.04%
Average Volume (3M)17.50K
Price to Earnings (P/E)83.8
Beta (1Y)0.56
Revenue Growth15.78%
EPS Growth15.01%
CountryIN
Employees9,052
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)4.60
Shares Outstanding268,790,370
10 Day Avg. Volume39,597
30 Day Avg. Volume17,497
Financial Highlights & Ratios
PEG Ratio101.90
Price to Book (P/B)9.77
Price to Sales (P/S)9.09
P/FCF Ratio308.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹1,440.00Price Target Upside18.36% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)25.88
Revenue Forecast (FY)₹50.12B
Global Health Limited Business Overview & Revenue Model
Company Description
Global Health Limited, a multi-specialty tertiary care provider, offers healthcare services in India. The company primarily offers treatments in the areas of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary scie...
How the Company Makes Money
Medanta primarily makes money by delivering hospital and clinical services to patients and billing for those services. Key revenue streams include: (1) Inpatient services—revenues from room/bed charges, nursing and care services, ICU stays, operat...
Global Health Limited Financial Statement Overview
Summary
Income Statement
92
Very Positive
Balance Sheet
85
Very Positive
Cash Flow
78
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.49B | 36.37B | 32.41B | 26.83B | 21.67B | 14.29B |
| Gross Profit | 30.12B | 27.57B | 24.82B | 20.58B | 16.24B | 10.81B |
| EBITDA | 9.84B | 9.05B | 8.72B | 6.77B | 4.90B | 2.23B |
| Net Income | 5.62B | 4.81B | 4.78B | 3.26B | 1.96B | 288.05M |
Balance Sheet | ||||||
| Total Assets | 54.10B | 47.66B | 43.04B | 41.16B | 31.46B | 26.94B |
| Cash, Cash Equivalents and Short-Term Investments | 12.55B | 10.51B | 11.56B | 12.60B | 5.12B | 2.89B |
| Total Debt | 9.45B | 7.18B | 8.02B | 11.22B | 11.09B | 9.31B |
| Total Liabilities | 16.99B | 13.79B | 13.98B | 16.88B | 15.30B | 13.12B |
| Stockholders Equity | 37.08B | 33.86B | 29.06B | 24.28B | 16.16B | 13.82B |
Cash Flow | ||||||
| Free Cash Flow | -841.82M | 1.07B | 3.33B | 4.09B | 367.87M | 960.32M |
| Operating Cash Flow | 3.29B | 6.24B | 6.12B | 6.45B | 3.11B | 2.42B |
| Investing Cash Flow | 464.62M | -7.21B | -4.41B | -3.42B | -4.21B | -2.39B |
| Financing Cash Flow | 1.54B | -972.26M | -5.14B | 3.46B | 1.60B | -807.23M |
Global Health Limited Technical Analysis
Negative
1216.65
Price Trends
1084.73
Negative
1135.66
Negative
1226.09
Negative
Market Momentum
-28.89
Negative
46.76
Neutral
75.19
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MEDANTA, the sentiment is Negative. The current price of 1216.65 is above the 20-day moving average (MA) of 1034.00, above the 50-day MA of 1084.73, and below the 200-day MA of 1226.09, indicating a bearish trend. The MACD of -28.89 indicates Negative momentum. The RSI at 46.76 is Neutral, neither overbought nor oversold. The STOCH value of 75.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:MEDANTA.
Global Health Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ₹347.20B | 75.82 | ― | 0.24% | 14.72% | 8.37% | |
65 Neutral | ₹277.16B | 83.79 | ― | 0.04% | 15.78% | 15.01% | |
65 Neutral | ₹256.05B | 114.01 | ― | ― | 25.74% | 1.41% | |
62 Neutral | ₹339.76B | 151.95 | ― | 0.84% | -36.14% | -93.99% | |
61 Neutral | ₹634.32B | 86.12 | ― | 0.11% | 15.33% | 54.62% | |
61 Neutral | ₹90.26B | 60.35 | ― | 0.21% | 15.41% | 5.93% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
IN:MEDANTA
Global Health Limited
1,031.15
-205.95
-16.65%
IN:ASTERDM
Aster DM Healthcare Ltd.
655.75
175.40
36.52%
IN:FORTIS
Fortis Healthcare Ltd.
840.20
192.02
29.62%
IN:KIMS
Krishna Institute of Medical Sciences Limited
639.90
56.05
9.60%
IN:METROPOLIS
Metropolis Healthcare Ltd.
435.35
50.98
13.26%
IN:NH
Narayana Hrudayalaya Ltd.
1,698.95
18.56
1.10%
Global Health Limited Corporate Events
Global Health Reports No Demat or Remat Activity for March Quarter
Apr 2, 2026
Global Health Limited has notified the stock exchanges that it has obtained the required quarterly certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 from its registrar and transfer agent, Kfin Technol...
Global Health Publishes Postal Ballot Voting Results and Scrutinizer’s Report
Mar 14, 2026
Global Health Limited, the operator of Medanta hospitals, is a listed Indian healthcare services company headquartered in New Delhi and focused on multi-specialty hospital care. It trades on both BSE and NSE under the symbol MEDANTA, serving patie...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.